Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep;34(9):e23362.
doi: 10.1002/jcla.23362. Epub 2020 May 28.

Effects of PAK4/LIMK1/Cofilin-1 signaling pathway on proliferation, invasion, and migration of human osteosarcoma cells

Zhi-Feng Li  1 , Yin-Di Yao  2 , Yin-Yin Zhao  3 , Yan Liu  4 , Zhen-Hua Liu  5 , Pei Hu  6 , Zhuo-Ran Zhu  7
Affiliations

Effects of PAK4/LIMK1/Cofilin-1 signaling pathway on proliferation, invasion, and migration of human osteosarcoma cells

Zhi-Feng Li et al. J Clin Lab Anal. 2020 Sep.

Abstract

Purpose: To explore the effects of PAK4/LIMK1/Cofilin-1 signaling pathway on the proliferation, invasion, and migration of human osteosarcoma cells.

Methods: The expression of PAK4/LIMK1/Cofilin-1 was detected by immunohistochemistry in osteosarcoma tissues. The osteosarcoma cell line MG63 was transfected and divided into Mock, Control siRNA, si-PAK4, LIMK1, and si-PAK4+LIMK1 groups. Then, the cellular biological features of MG63 cells were detected by CCK-8, wound-healing, Transwell, and flow cytometry methods. The relationship of PAK4 and LIMK1 was performed by co-immunoprecipitation test, and the protein expression of PAK4/LIMK1/Cofilin-1 was determined by Western blotting. Finally, the effect of PAK4 on the growth of osteosarcoma was verified by subcutaneous transplantation model of osteosarcoma in nude mice.

Results: The expression of PAK4/LIMK1/Cofilin-1 in both osteosarcoma tissues and cells was up-regulated. Positive PAK4, LIMK1, and Cofilin-1 expressions in osteosarcoma were associated with the clinical stage, distant metastasis, and tumor grade. The MG63 cell viability, migration, and invasion, as well as the expression of PAK4, p-LIMK/LIMK, and p-Cofilin-1/Cofilin-1, were restrained by the knock down of PAK4 while it promoted apoptosis. PAK4 silencing also suppressed the growth of subcutaneous transplanted tumor in nude mice. Co-immunocoprecipitation showed that LIMK and PAK4 protein can form complex in osteosarcoma cells. Besides, LIMK1 overexpression reversed the inhibition effect of PAK4 siRNA on the growth of osteosarcoma cells.

Conclusion: The expression of PAK4/LIMK1/Cofilin-1 pathway in osteosarcoma tissues was up-regulated. Thus, PAK4 inhibition may restrict the osteosarcoma cell proliferation, invasion, and migration but promote its apoptosis via decreasing the activity of LIMK1/Cofilin-1 pathway.

Keywords: Cofilin-1; LIMK1; PAK4; osteosarcoma.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there is no conflict of interests regarding the publication of this paper.

Figures

FIGURE 1
FIGURE 1
Expression of PAK4/LIMK1/Cofilin‐1 in osteosarcoma tissues and cells. A, The expression of PAK4/LIMK1/Cofilin‐1 in osteosarcoma tissues and adjacent non‐tumor tissues detected by immunohistochemistry; B, The protein expression of PAK4, LIMK1, and Cofilin‐1 in osteosarcoma cell lines and osteoblasts cells determined by Western blotting, *, Compared with osteoblasts hFOB1.19, P < .05
FIGURE 2
FIGURE 2
Comparison of the proliferation and apoptosis of transfected osteosarcoma cells in each group. A, The proliferation of MG63 cells in each transfected group detected by CCK‐8 method; B, The apoptosis of MG63 cells in each transfected group measured by flow cytometry; *, Compared with Mock group; P < .05; #, Compared with si‐PAK4 group, P < .05; %, Compared with LIMK1 group, P < .05
FIGURE 3
FIGURE 3
Comparison of invasion and migration of MG63 cells in each transfected group. A,B, Detection of the migration ability of MG63 cells in each transfected group with wound‐healing test; C,D, Measurement of the invasion ability of osteosarcoma cells in each transfected group with Transwell test. *, Compared with Mock group, P < .05; #, Compared with si‐PAK4 group, P < .05; %, Compared with LIMK1 group, P < .05
FIGURE 4
FIGURE 4
The protein expression of PAK4/LIMK1/Cofilin‐1 in MG63 cells in each group. A, The relationship between PAK4 and LIMK1 detected by co‐immunoprecipitation method; B,C, Determination of the protein expression of PAK4/LIMK1/Cofilin‐1 in MG63 cells in each group by using Western blotting, *, Compared with Mock group, P < .05; #, Compared with si‐PAK4 group, P < .05; %, Compared with LIMK1 group, P < .05
FIGURE 5
FIGURE 5
Comparison of subcutaneous tumor of nude mice in each group. A, Growth curve of nude mice in each group; B, Representative images of the tumor morphology in nude mice; C, Comparison of the weight of transplanted tumor of nude mice in each group, *, Compared with Mock group, P < .05; #, Compared with si‐PAK4 group, P < .05; %, Compared with LIMK1 group, P < .05
See this image and copyright information in PMC

References

    1. Wu PK, Chen WM, Lee OK, et al. The prognosis for patients with osteosarcoma who have received prior manipulative therapy. J Bone Joint Surg Br. 2010;92(11):1580‐1585. - PubMed
    1. Anderson ME. Update on survival in osteosarcoma. Orthop Clin North Am. 2016;47(1):283‐292. - PubMed
    1. Clark JC, Dass CR, Choong PF. A review of clinical and molecular prognostic factors in osteosarcoma. J Cancer Res Clin Oncol. 2008;134(3):281‐297. - PMC - PubMed
    1. Janeway KA, Grier HE. Sequelae of osteosarcoma medical therapy: a review of rare acute toxicities and late effects. Lancet Oncol. 2010;11(7):670‐678. - PubMed
    1. Kushlinskii NE, Fridman MV, Braga EA. Molecular mechanisms and microRNAs in osteosarcoma pathogenesis. Biochemistry (Moscow). 2016;81(4):315‐328. - PubMed

MeSH terms